2025-03-29 18:17:01
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Zim Laboratories Ltd posts higher consolidated PAT of Rs. 6.60 crores in Q3FY23
Posted On : 2023-02-04 10:27:55( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 103.3747 crores during the period ended December 31, 2022 as compared to Rs. 100.8204 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 6.6006 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 5.4497 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 1.35 for the period ended December 31, 2022 as compared to Rs. 1.12 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹103.3747 crs | ₹100.8204 crs |  2.53% |
| Net Profit | ₹6.6006 crs | ₹5.4497 crs | 21.12% |
| EPS | ₹1.35 | ₹1.12 | 20.54% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.103.3747 crores during the period ended December 31, 2022 as compared to Rs.87.4007 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.6.6006 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.4.0727 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.1.35 for the period ended December 31, 2022 as compared to Rs.0.84 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹103.3747 crs | ₹87.4007 crs | 18.28% |
| Net Profit | ₹6.6006 crs | ₹4.0727 crs | 62.07% |
| EPS | ₹1.35 | ₹0.84 | 60.71% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.298.8353 crores during the 9 Months period ended December 31, 2022 as compared to Rs.231.1386 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.17.1981 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.7.5202 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.3.53 for the 9 Months period ended December 31, 2022 as compared to Rs.1.54 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹298.8353 crs | ₹231.1386 crs | 29.29% |
| Net Profit | ₹17.1981 crs | ₹7.5202 crs | 128.69% |
| EPS | ₹3.53 | ₹1.54 | 129.22% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 81.30 as compared to the previous close of Rs. 82.75. The total number of shares traded during the day was 1445 in over 126 trades.
The stock hit an intraday high of Rs. 84.85 and intraday low of 78.65. The net turnover during the day was Rs. 116879.00.
